تداخل‌های دارویی
Alogliptin-pioglitazone + Mecasermin
شدت: متوسط
Alogliptin-pioglitazone and Mecasermin: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Mecasermin is recombinant IGF-1 and has insulin-like glucose-lowering effects. Added to antidiabetic drugs it can increase the risk of hypoglycemia. Mecasermin must be given with food for this reason.
معنای این تداخل به زبان ساده
Alogliptin-pioglitazone and Mecasermin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Alogliptin-pioglitazone belongs to Endocrine; Mecasermin belongs to Endocrine.
چرا رخ می‌دهد
Additive pharmacodynamic glucose-lowering through insulin-like activity of IGF-1.
اقدام لازم
Monitor blood glucose closely when starting mecasermin and consider lowering antidiabetic doses. Give mecasermin with or shortly after a meal and educate the patient on hypoglycemia symptoms.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Alogliptin-pioglitazone و Mecasermin، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Alogliptin-pioglitazone
تداخلات دیگر Mecasermin
پرسش‌های متداول
Can I take Alogliptin-pioglitazone with Mecasermin?
MediHelp rates the interaction as moderate. Alogliptin-pioglitazone and Mecasermin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Mecasermin is recombinant IGF-1 and has insulin-like glucose-lowering effects. Added to antidiabetic drugs it can increase the risk of hypoglycemia. Mecasermin must be given with food for this reason.
How serious is the interaction between Alogliptin-pioglitazone and Mecasermin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting mecasermin and consider lowering antidiabetic doses. Give mecasermin with or shortly after a meal and educate the patient on hypoglycemia symptoms.
What other medicines interact with Alogliptin-pioglitazone?
MediHelp also lists interactions of Alogliptin-pioglitazone with, for example, Gemfibrozil, Insulin aspart, Insulin degludec. The full list is on the Alogliptin-pioglitazone page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
